1. Home
  2. SVRA vs PML Comparison

SVRA vs PML Comparison

Compare SVRA & PML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • PML
  • Stock Information
  • Founded
  • SVRA N/A
  • PML 2002
  • Country
  • SVRA United States
  • PML United States
  • Employees
  • SVRA N/A
  • PML N/A
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • PML Investment Managers
  • Sector
  • SVRA Health Care
  • PML Finance
  • Exchange
  • SVRA Nasdaq
  • PML Nasdaq
  • Market Cap
  • SVRA 552.6M
  • PML 593.8M
  • IPO Year
  • SVRA N/A
  • PML N/A
  • Fundamental
  • Price
  • SVRA $3.24
  • PML $8.58
  • Analyst Decision
  • SVRA Buy
  • PML
  • Analyst Count
  • SVRA 6
  • PML 0
  • Target Price
  • SVRA $10.83
  • PML N/A
  • AVG Volume (30 Days)
  • SVRA 2.0M
  • PML 188.0K
  • Earning Date
  • SVRA 11-12-2024
  • PML 01-01-0001
  • Dividend Yield
  • SVRA N/A
  • PML 5.65%
  • EPS Growth
  • SVRA N/A
  • PML N/A
  • EPS
  • SVRA N/A
  • PML N/A
  • Revenue
  • SVRA N/A
  • PML N/A
  • Revenue This Year
  • SVRA N/A
  • PML N/A
  • Revenue Next Year
  • SVRA N/A
  • PML N/A
  • P/E Ratio
  • SVRA N/A
  • PML N/A
  • Revenue Growth
  • SVRA N/A
  • PML N/A
  • 52 Week Low
  • SVRA $2.82
  • PML $6.92
  • 52 Week High
  • SVRA $5.70
  • PML $9.46
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 41.82
  • PML 34.78
  • Support Level
  • SVRA $2.82
  • PML $8.71
  • Resistance Level
  • SVRA $4.30
  • PML $8.82
  • Average True Range (ATR)
  • SVRA 0.30
  • PML 0.14
  • MACD
  • SVRA -0.05
  • PML -0.03
  • Stochastic Oscillator
  • SVRA 28.72
  • PML 1.47

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About PML Pimco Municipal Income Fund II of Beneficial Interest

PIMCO Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal income tax. The fund portfolio of investments consists of investments in different sectors such as education, healthcare, and others.

Share on Social Networks: